MediXall Group, Inc. Stock Other OTC
Equities
MDXL
US58504K1043
Advanced Medical Equipment & Technology
Sales 2021 | 15K 20.44K | Sales 2022 | 59.27K 80.78K | Capitalization | 77.59M 106M |
---|---|---|---|---|---|
Net income 2021 | -6M -8.18M | Net income 2022 | -6M -8.18M | EV / Sales 2021 | 7,599 x |
Net Debt 2021 | 252K 344K | Net Debt 2022 | 2.82M 3.84M | EV / Sales 2022 | 1,357 x |
P/E ratio 2021 |
-17
x | P/E ratio 2022 |
-10.5
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 85.16% |
Managers | Title | Age | Since |
---|---|---|---|
Travis Jackson
CEO | Chief Executive Officer | - | 22-06-13 |
Shane Glavin
DFI | Director of Finance/CFO | - | 12-05 |
Frank Dickerson
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Marino
CEO | Chief Executive Officer | 52 | 13-05-31 |
Travis Jackson
CEO | Chief Executive Officer | - | 22-06-13 |
Robert Hood
BRD | Director/Board Member | - | 23-10-09 |
1st Jan change | Capi. | |
---|---|---|
+12.06% | 227B | |
+12.07% | 192B | |
+13.88% | 136B | |
+27.12% | 108B | |
+0.49% | 64.07B | |
+13.39% | 52.1B | |
+6.74% | 51.87B | |
+8.81% | 44.33B | |
+4.14% | 36.75B |